US Bancorp’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-500
| Closed | -$25.3K | – | 4191 |
|
|
2024
Q4 | $25.3K | Hold |
500
| – | – | ﹤0.01% | 3058 |
|
|
2024
Q3 | $31.9K | Hold |
500
| – | – | ﹤0.01% | 2946 |
|
|
2024
Q2 | $29.6K | Hold |
500
| – | – | ﹤0.01% | 2894 |
|
|
2024
Q1 | $28.8K | Hold |
500
| – | – | ﹤0.01% | 2938 |
|
|
2023
Q4 | $28.5K | Hold |
500
| – | – | ﹤0.01% | 2910 |
|
|
2023
Q3 | $24K | Hold |
500
| – | – | ﹤0.01% | 2790 |
|
|
2023
Q2 | $26K | Hold |
500
| – | – | ﹤0.01% | 2818 |
|
|
2023
Q1 | $27.1K | Hold |
500
| – | – | ﹤0.01% | 2823 |
|
|
2022
Q4 | $28.9K | Hold |
500
| – | – | ﹤0.01% | 2796 |
|
|
2022
Q3 | $23K | Hold |
500
| – | – | ﹤0.01% | 2939 |
|
|
2022
Q2 | $25K | Hold |
500
| – | – | ﹤0.01% | 2914 |
|
|
2022
Q1 | $31K | Hold |
500
| – | – | ﹤0.01% | 2827 |
|
|
2021
Q4 | $40K | Sell |
500
-37
| -7% | -$2.96K | ﹤0.01% | 2749 |
|
|
2021
Q3 | $51K | Hold |
537
| – | – | ﹤0.01% | 2637 |
|
|
2021
Q2 | $53K | Buy |
537
+37
| +7% | +$3.65K | ﹤0.01% | 2629 |
|
|
2021
Q1 | $42K | Hold |
500
| – | – | ﹤0.01% | 2652 |
|
|
2020
Q4 | $43K | Hold |
500
| – | – | ﹤0.01% | 2561 |
|
|
2020
Q3 | $35K | Hold |
500
| – | – | ﹤0.01% | 2529 |
|
|
2020
Q2 | $36K | Hold |
500
| – | – | ﹤0.01% | 2503 |
|
|
2020
Q1 | $23K | Hold |
500
| – | – | ﹤0.01% | 2621 |
|
|
2019
Q4 | $31K | Buy |
+500
| New | +$31K | ﹤0.01% | 2670 |
|